Medicale Corp. (MCLE)
Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014
Balance Sheet Date2025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312021-Mar-312020-Dec-31
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q2-FY2021Q1-FY2021
Close Price of Common Stock
Market Cap of Common Stock
QoQ%
YoY%
Common Shares Outstanding5,920,0005,920,0005,920,0005,920,0005,920,0005,920,0005,920,0005,920,0005,920,0005,920,0005,920,0005,920,0005,920,0005,920,0005,920,0003,400,000
QoQ%.00%.00%.00%.00%.00%.00%.00%.00%.00%.00%.00%.00%74.12%
YoY%.00%.00%.00%.00%.00%.00%.00%.00%.00%.00%
Price to Sales
Price to Earnings
Price to Book
Total Revenue0$0$
QoQ%.00%
YoY%
TTM
TTM_QoQ%
TTM_YoY%
Gross Margin
QoQ
YoY
Operating Income(8,654$)(3,575$)(6,269$)(14,995$)(15,509$)(9,288$)(10,603$)(19,307$)(14,227$)(8,537$)(6,115$)(8,714$)(7,175$)(11,514$)
QoQ%(142.07%)42.97%58.19%3.31%(66.98%)12.40%45.08%(35.71%)(66.65%)(39.61%)29.83%37.69%
YoY%44.20%61.51%40.88%22.33%(9.01%)(8.80%)(73.39%)(121.56%)
TTM(33,493$)(40,348$)(46,061$)(50,395$)(54,707$)(53,425$)(52,674$)(48,186$)(37,593$)
TTM_QoQ%16.99%12.40%8.60%7.88%(2.40%)(1.43%)(9.31%)(28.18%)
TTM_YoY%38.78%24.48%12.56%(4.58%)(45.52%)
Operating Margin
QoQ
YoY
Net Income(10,670$)(5,528$)(8,275$)(16,680$)(16,881$)(10,461$)(11,564$)(19,307$)(14,227$)(8,537$)(6,115$)(8,259$)(7,175$)(11,514$)
QoQ%(93.02%)33.20%50.39%1.19%(61.37%)9.54%40.11%(35.71%)(66.65%)(39.61%)25.96%37.69%
YoY%36.79%47.16%28.44%13.61%(18.66%)(22.54%)(89.11%)(133.77%)
TTM(41,153$)(47,364$)(52,297$)(55,586$)(58,213$)(55,559$)(53,635$)(48,186$)(37,138$)
TTM_QoQ%13.11%9.43%5.92%4.51%(4.78%)(3.59%)(11.31%)(29.75%)
TTM_YoY%29.31%14.75%2.50%(15.36%)(56.75%)
Profit Margin
QoQ
YoY
Equity to Common Shareholders(140,086$)(129,416$)(123,888$)(115,613$)(98,933$)(82,052$)(71,591$)(60,027$)(40,720$)(26,493$)(17,956$)(11,841$)(54,774$)5,108$(12,917$)(1,403$)
QoQ(10,670$)(5,528$)(8,275$)(16,680$)(16,881$)(10,461$)(11,564$)(19,307$)(14,227$)(8,537$)(6,115$)42,933$18,025$(11,514$)
QoQ%(8.25%)(4.46%)(7.16%)(16.86%)(20.57%)(14.61%)(19.27%)(47.41%)(53.70%)(47.54%)(51.64%)78.38%139.55%(820.67%)
YoY(41,153$)(47,364$)(52,297$)(55,586$)(58,213$)(55,559$)(53,635$)(48,186$)14,054$
YoY%(41.60%)(57.72%)(73.05%)(92.60%)(142.96%)(209.71%)(298.70%)(406.94%)25.66%
Dividends Paid
Additional Paid-In Capital QoQ0$0$0$0$0$0$0$0$24,948$0$
Treasury Stock
QoQ
Goodwill
QoQ%
YoY%
Other Intangible Assets0$0$0$0$10,800$11,400$12,000$
QoQ0$0$0$(600$)(600$)
Amortization of Intangible Assets
Total Assets159$159$159$159$159$159$34,900$11,600$12,200$
QoQ0$0$0$0$0$23,300$(600$)
YoY0$0$
Total Liabilities140,086$129,416$123,888$115,772$99,092$82,211$71,750$60,186$40,879$29,792$24,517$13,603$
QoQ10,670$5,528$8,116$16,680$16,881$10,461$11,564$19,307$5,275$10,914$
YoY40,994$47,205$52,138$55,586$58,213$
Current Ratio.01x.01x.01x.01x.01x-.81x.01x.01x
Total Current Assets159$159$159$159$159$159$24,100$200$200$
QoQ0$0$0$0$0$23,900$0$
Total Current Liabilities33,652$29,439$25,932$22,187$15,507$14,135$12,962$12,000$40,879$29,792$24,517$13,603$
QoQ4,213$3,507$3,745$6,680$1,372$1,173$962$(28,879$)5,275$10,914$
Debt to Asset Ratio728.13x623.22x517.05x451.26x378.53x257.10x.85x2.11x1.12x
Long Term Debt
QoQ
YoY
Capital Lease Obligations
Cash and Cash Equivalents23,900$0$0$
QoQ23,900$0$
YoY
Interest Expenses
Interest Income